Zobrazeno 1 - 10
of 66
pro vyhledávání: '"I. I Chukaeva"'
Publikováno v:
КардиоСоматика, Vol 8, Iss 3, Pp 29-38 (2017)
In the article, the main provisions of the recommendations of the European Society of Cardiology and the Association for Heart Failure 2016 are presented in the abstract. The new classification is presented, the approaches to diagnostics and pharmaco
Externí odkaz:
https://doaj.org/article/5b10b1617b5140beb7a1099af1d2877d
Publikováno v:
КардиоСоматика, Vol 4, Iss 1-1 (2013)
Цель. Проведение скринингового обследования населения с целью выявления факторов риска сердечно-сосудистых заболеваний и их коррекции
Externí odkaz:
https://doaj.org/article/f9dc074888ba43999f8c598ce79abc2e
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 2, Pp 166-173 (2019)
Aim. To assess efficacy and safety of single-pill combination (SPC) amlodipine/perindopril and amlodipine/indapamide/perindopril in patients with uncontrolled hypertension (HT) in routine clinical practice.Material and methods. 16144 patients with un
Externí odkaz:
https://doaj.org/article/d61eebf1a0524ff5918056c89a385575
Autor:
N. V. Orlova, I. I. Chukaeva
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 58-64 (2017)
Acute respiratory viral infection(ARVI) are the most common diseases in the world. Acute respiratory viral infections (ARI), including influenza, include a group of infectious diseases of the respiratory tract with a viral etiology and are predominan
Externí odkaz:
https://doaj.org/article/762fba4d575549b99fb1357ab24adcdf
Publikováno v:
Системные гипертензии, Vol 14, Iss 2, Pp 36-40 (2017)
Introduction. Combined antihypertensive therapy is indicated in 94% of patients with hypertension. Fixed combinations are preferable to use as they have a high profile of effectiveness, safety, more convenient to use and significantly increase the ad
Externí odkaz:
https://doaj.org/article/826cd02bb9e446a1bb1977230560df2d
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 16, Iss 3, Pp 46-51 (2017)
Aim. To investigate on the factors determining the adherence to optimal treatment in older age patients with chronic heart failure (CHF) in outpatient setting.Material and methods. Into the open, comparative single-movement non-randomized study, 80 C
Externí odkaz:
https://doaj.org/article/fabe6bba578b45e1844f58e45729093e
Publikováno v:
Медицинский совет, Vol 0, Iss 13, Pp 24-27 (2016)
The high prevalence of arterial hypertension (AH) – up to 40% of the whole population (and more than 50% among elderly patients) – makes it one of the most important problems of the modern medicine. In the report of the World Health Organization
Externí odkaz:
https://doaj.org/article/41cb2184922d488f98c97d7b95db7295
Autor:
N. M. Achmegdanov, S. A. Butrusova, I. I. Dedov, L. A. Zvenigorodskaya, O. A. Kislyak, O. A. Koshelskaya, I. V. Kuznecova, V. V. Kuharchuk, A. Yu. Litvin, I. V. Medvedeva, A. M. Mkrtumyan, V. B. Mychka, D. V. Nebieridze, S. V. Nedogoda, R. G. Oganov, M. Yu. Ogarkov, N. B. Perepech, V. I. Podzolkov, V. P. Smetnik, A. V. Susekov, V. N. Titov, T. V. Tyurina, A. N. Fursov, V. N. Hirmanov, I. E. Chazova, I. I. Chukaeva, M. V. Shestakova, A. T. Shubina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 6, Iss 4, Pp 599-606 (2016)
Russian Experts’ Consensus on Metabolic Syndrome Problem in the Russian Federation: Defenition, Diagnosis Criteria, Primary Prevention and Treatment.
Externí odkaz:
https://doaj.org/article/b0d7c7c4bf1f43db936192ee633a9513
Autor:
I E Chazova, Yu A Karpov, I I Chukaeva, O A Kislyak, Yu V Zhernakova, T V Martynuk, A Yu Litvin
Publikováno v:
Системные гипертензии, Vol 12, Iss 3, Pp 6-10 (2015)
Как показывают фармакоэпидемиологические исследования, роль комбинированной терапии в лечении АГ становится все более важной и все бо
Externí odkaz:
https://doaj.org/article/a049cf6167ac4494a3e8b6343f6c8713
Autor:
I. I. Chukaeva, Ya. G. Spiryakina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 9, Iss 6, Pp 660-663 (2015)
In patients with arterial hypertension (HT) heart is affected earlier and more often than other target organs, left ventricular hypertrophy (LVH) develops. Considering the proven link between the presence of LVH and increased cardiovascular risk, the
Externí odkaz:
https://doaj.org/article/204d63d81722419ea5c9e8d538d4547e